文献速递生殖医学

考量辅助生殖技术中的最小临床重要差异

Considering minimal clinically important differences in assisted reproductive technology.
PubMed 文献 · Fertil Steril · 2025-06-25

本文为专家意见,讨论辅助生殖技术文献中最小临床重要差异(MCID)的报告问题,并探讨绝对差异与相对差异在定义该参数时的效用。作者建议比较研究应在设计阶段纳入明确且合理的最小临床重要差异阈值,并以相对指标表达差异,同时报告绝对指标以保完整性。

要点

  • 解读研究结果需同时考虑统计学显著性与临床显著性,核心是确立对患者有益的最小临床重要差异。
  • 辅助生殖技术中常用取卵数均值、妊娠率、临床妊娠、活产及累积活产等基准评估治疗差异。
  • 作者建议比较研究设计时应预先定义并合理说明最小临床重要差异阈值,以相对指标表达差异,同时报告绝对指标。

核心结论

  • 作者建议最小临床重要差异应预先定义并以相对指标表达,以便在不同预后女性群体间解读,同时报告绝对指标以保完整性。

研究设计与样本

  • 专家意见;受试者不适用;暴露不适用。

主要发现

  • 确定辅助生殖技术操作的最小临床重要差异是主观过程,受选择绝对差异还是相对差异等因素影响。
  • 不同研究中使用了多种且常重叠的最小临床重要差异,导致治疗与对照间相同差异在某些研究中被解读为优效性证据,在另一些研究中被解读为非劣效性证据。

关键数值与推荐

  • 作者推荐比较研究应通过设计纳入明确且合理说明的最小临床重要差异阈值,并以相对指标表达差异。
  • 作者推荐最小临床重要差异应预先定义并以相对指标表达,同时报告绝对指标以保完整性。

临床怎么用

  • 作者建议在辅助生殖技术的比较研究中预先定义并合理说明最小临床重要差异阈值,以相对指标表达差异,同时报告绝对指标。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To address the reporting of minimal clinically important differences (MCIDs) in the published literature and investigate the utility of absolute and relative differences when defining this parameter. DESIGN: Expert opinion. SUBJECTS: Not applicable. EXPOSURE: Not applicable. MAIN OUTCOME MEASURES: It is essential to consider both statistical significance and clinical significance when interpreting study findings. Key to this is establishing the MCID that is beneficial for patients. In the context of assisted reproductive technology, several benchmarks are used to evaluate differences between treatments, including the mean number of retrieved oocytes, pregnancy rates, clinical pregnancies, live births, and cumulative live births. RESULTS: Determining the MCID for assisted reproductive technology procedures is a subjective process that can be influenced by several factors, depending on whether an absolute or relative difference is selected. Furthermore, various and often overlapping MCIDs have been used in different studies, meaning that the same difference between treatment and comparator can be interpreted as evidence of superiority in some studies and as evidence of noninferiority in others. To address these inconsistencies, we recommend that comparative studies should, by design, include a clearly defined and justified MCID threshold, with differences expressed as relative measures. CONCLUSION: We recommend that the MCID should be defined in advance and expressed as a relative measure, which can be interpreted across various groups of women with diverse prognoses. However, absolute measures should also be reported for completeness.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Schwarze JE, Broekmans F, Gupta S, et al. Considering minimal clinically important differences in assisted reproductive technology. Fertil Steril. 2025. PMID: 40578658. doi:10.1016/j.fertnstert.2025.06.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。